Form 4 · Filed Jun 25, 2026, 10:38 PM UTC
NRIX/Nurix Therapeutics, Inc.
Ring Christine — Chief Legal Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
5 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | M | other | 13,333 | $7 | $96,798 | 26,912 |
| Jun 25, 2026 | M | other | 15,602 | $9 | $136,049 | 42,514 |
| Jun 25, 2026 | S | sell | 28,935 | $20 | $580,506 | 13,579 |
| Jun 25, 2026 | M | other | 13,333 | — | — | 0 |
| Jun 25, 2026 | M | other | 15,602 | — | — | 134,398 |
Source: SEC EDGAR raw filing ↗ · Accession 0001817199-26-000022